» Authors » Angeliki Theodoropoulou

Angeliki Theodoropoulou

Explore the profile of Angeliki Theodoropoulou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 403
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Torre I, Doyon L, Benito-Calvo A, Mora R, Mwakyoma I, Njau J, et al.
Nature . 2025 Mar; PMID: 40044851
Recent evidence indicates that the emergence of stone tool technology occurred before the appearance of the genus Homo and may potentially be traced back deep into the primate evolutionary line....
2.
Goren I, Fallek Boldes O, Boldes T, Knyazev O, Kagramanova A, Limdi J, et al.
J Crohns Colitis . 2024 Oct; PMID: 39435855
Objectives: Elderly hospitalized patients with inflammatory bowel disease (IBD) flare and concurrent Clostridioides difficile infection (CDI) are considered at high risk of IBD-related complications. We aimed to evaluate the short,...
3.
Papathanasiou E, Kokkotis G, Axiaris G, Bellou G, Chalakatevaki K, Christidou A, et al.
Eur J Gastroenterol Hepatol . 2024 Sep; 37(2):154-160. PMID: 39324945
Background: Inflammatory bowel disease (IBD) commonly affects patients of reproductive age. The effect of disease activity on the outcome of pregnancy and its impact on neonatal health are areas of...
4.
Paspatis G, Fragaki M, Arna D, Velegraki M, Psistakis A, Nicolaou P, et al.
Dig Liver Dis . 2024 Jul; 57(1):44-50. PMID: 39013709
Objectives: Data of long-term follow up for large non pedunculated colorectal polyps (LNPCPs) ≥4 cm removed with piecemeal wide field endoscopic mucosal resection (PWF-EMR) are limited. We primarily evaluated the...
5.
Allocca M, Catalano G, Savarino E, Chaparro M, Levartovsky A, Michalopoulos G, et al.
United European Gastroenterol J . 2024 Feb; 12(5):543-551. PMID: 38419274
Background: Ustekinumab and tofacitinib have recently been approved for the management of moderate to severe ulcerative colitis (UC). However, there is no evidence on how they should be positioned in...
6.
Katsoula A, Axiaris G, Mpitouli A, Palatianou M, Christidou A, Dimitriadis N, et al.
J Clin Med . 2023 Apr; 12(8). PMID: 37109360
Background: The Inflammatory Bowel Disease-Disk (IBD-Disk) is a physician-administered tool that evaluates the functional status of patients with Inflammatory Bowel Disease (IBD). The aim of our study was to validate...
7.
Mantzaris G, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K, et al.
Crohns Colitis 360 . 2023 Feb; 3(4):otab064. PMID: 36777275
Background: Data on the effectiveness of anti-tumor necrosis factor medications in patients with Crohn's disease (CD) with poor prognostic factors (PPFs) are scarce. This study aimed to generate real-world evidence...
8.
Ellul P, Schembri J, Vella Baldacchino A, Molnar T, Resal T, Allocca M, et al.
J Crohns Colitis . 2022 Nov; 17(4):489-496. PMID: 36322687
Background And Aims: Post-inflammatory polyps [PIPs] are considered as indicators of previous episodes of severe inflammation and mucosal ulceration. Inflammatory bowel disease [IBD], namely Crohn's disease [CD] and ulcerative colitis...
9.
Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, et al.
Inflamm Bowel Dis . 2022 Apr; 29(2):228-237. PMID: 35394529
Background: Four EMA-approved vaccines against SARS-CoV-2 are currently available. Data regarding antibody responses to initial vaccination regimens in patients with inflammatory bowel diseases (IBD) are limited. Methods: We conducted a...
10.
Paspatis G, Papastergiou V, Mpitouli A, Velegraki M, Nikolaou P, Fragkaki M, et al.
Dig Dis Sci . 2022 Mar; 67(9):4557-4564. PMID: 35305168
Background: Prolonged biliary stenting may be considered in high-risk patients with irretrievable bile duct stones (IBDS). Distal stent migration (DSM) is a known complication, although data beyond the recommended interval...